Gilead boosts low-cost HIV drug program for developing countries

Four Indian drug manufactures can make Gilead Sciences Inc.’s experimental “Quad” pill, and Gilead became the first drug maker to sign a deal with a newly formed patent pool, under deals that will deliver lower-cost HIV/AIDS drugs to the developing world.